Epistasis between Pax6Sey and genetic background reinforces the value of defined hybrid mouse models for therapeutic trials
File(s)Hickmott et al Epistatic Sey Phenotype Supplement.pdf (917.73 KB)
Supporting information
OA Location
Author(s)
Hickmott, Jack W
Gunawardane, Uvini
Jensen, Kimberly
Korecki, Andrea J
Simpson, Elizabeth M
Type
Journal Article
Abstract
The small eye (Sey) mouse is a model of PAX6-aniridia syndrome (aniridia). Aniridia, a congenital ocular disorder caused by heterozygous loss-of-function mutations in PAX6, needs new vision saving therapies. However, high phenotypic variability in Sey mice makes development of such therapies challenging. We hypothesize that genetic background is a major source of undesirable variability in Sey mice. Here we performed a systematic quantitative examination of anatomical, histological, and molecular phenotypes on the inbred C57BL/6J, hybrid B6129F1, and inbred 129S1/SvImJ backgrounds. The Sey allele significantly reduced eye weight, corneal thickness, PAX6 mRNA and protein levels, and elevated blood glucose levels. Surprisingly, Pax6Sey/Sey brains had significantly elevated Pax6 transcripts compared to Pax6+/+ embryos. Genetic background significantly influenced 12/24 measurements, with inbred strains introducing severe ocular and blood sugar phenotypes not observed in hybrid mice. Additionally, significant interactions (epistasis) between Pax6 genotype and genetic background were detected in measurements of eye weight, cornea epithelial thickness and cell count, retinal mRNA levels, and blood glucose levels. The number of epistatic interactions was reduced in hybrid mice. In conclusion, severe phenotypes in the unnatural inbred strains reinforce the value of more naturalistic F1 hybrid mice for the development of therapies for aniridia and other disorders.
Date Issued
2018-09-26
Date Acceptance
2018-09-05
Citation
Gene Therapy, 2018, 25, pp.524-537
ISSN
0969-7128
Publisher
Springer Nature [academic journals on nature.com]
Start Page
524
End Page
537
Journal / Book Title
Gene Therapy
Volume
25
Copyright Statement
© Springer Nature Limited 2018.
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/30258099
PII: 10.1038/s41434-018-0043-6
Subjects
06 Biological Sciences
11 Medical And Health Sciences
Biotechnology
Publication Status
Published
Coverage Spatial
England